Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Naber

Showing results (151-160 of 195) with videos related to

Pageof 20
Sort By:
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychoticsB G Schimmelmann, S Moritz, A Karow, et al.
Psychiatry Research|August 1, 1981
Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteersD R Rubinow, R M Post, D Pickar, et al.
Psychiatry Research|August 1, 1981
Sleep deprivation: effects on circadian rhythms of rat brain neurotransmitter receptorsA Wirz-Justice, I Tobler, M S Kafka, et al.
Pharmacopsychiatry|September 3, 2008
Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorderM Lambert, C G Huber, D Naber, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 3, 2003
CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificityS Ganzer, S Arlt, V Schoder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1996
Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor geneM Rietschel, D Naber, H Oberländer, et al.
Archives of General Psychiatry|January 1, 1994
WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findingsM Maj, P Satz, R Janssen, et al.
Psychopharmacology Bulletin|October 1, 1980
Antidepressant drugs slow circadian rhythms in behavior and brain neurotransmitter receptors [proceedings]A Wirz-Justice, T A Wehr, F K Goodwin, et al.
Acta Psychiatrica Scandinavica|July 5, 2005
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosisM Lambert, P Conus, D I Lubman, et al.
Pharmacopsychiatry|February 12, 2005
A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-beingM Kluge, P M Wehmeier, R W Dittmann, et al.
Pageof 20

Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
International Journal of Psychiatry in Clinical Practice|June 17, 2014
Correlates of subjective well-being in schizophrenic patients treated with atypical antipsychoticsB G Schimmelmann, S Moritz, A Karow, et al.
Psychiatry Research|August 1, 1981
Relationship between urinary free cortisol and CSF opioid binding activity in depressed patients and normal volunteersD R Rubinow, R M Post, D Pickar, et al.
Psychiatry Research|August 1, 1981
Sleep deprivation: effects on circadian rhythms of rat brain neurotransmitter receptorsA Wirz-Justice, I Tobler, M S Kafka, et al.
Pharmacopsychiatry|September 3, 2008
Treatment of severe agitation with olanzapine in 166 patients with schizophrenia, schizoaffective, or bipolar I disorderM Lambert, C G Huber, D Naber, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|October 3, 2003
CSF-tau, CSF-Abeta1-42, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificityS Ganzer, S Arlt, V Schoder, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 1, 1996
Efficacy and side-effects of clozapine: testing for association with allelic variation in the dopamine D4 receptor geneM Rietschel, D Naber, H Oberländer, et al.
Archives of General Psychiatry|January 1, 1994
WHO Neuropsychiatric AIDS study, cross-sectional phase II. Neuropsychological and neurological findingsM Maj, P Satz, R Janssen, et al.
Psychopharmacology Bulletin|October 1, 1980
Antidepressant drugs slow circadian rhythms in behavior and brain neurotransmitter receptors [proceedings]A Wirz-Justice, T A Wehr, F K Goodwin, et al.
Acta Psychiatrica Scandinavica|July 5, 2005
The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosisM Lambert, P Conus, D I Lubman, et al.
Pharmacopsychiatry|February 12, 2005
A simple switching strategy for inadequately treated patients with schizophrenia to olanzapine: changes in psychopathology and subjective well-beingM Kluge, P M Wehmeier, R W Dittmann, et al.
Pageof 20